BE CARINGBE CARING

BE CARING – a study to learn more about bimekizumab in breastfeeding mothers

Are you a breastfeeding mother currently taking bimekizumab? You might be interested in the BE CARING Study, which is collecting information on bimekizumab in breast milk.

Taking medications during 
pregnancy and breastfeeding

Taking medications during 
pregnancy and breastfeeding

Deciding whether to start a family can be a difficult choice to make for women with chronic diseases who rely on taking medications to control their disease. Because testing new drugs on pregnant or breastfeeding women can be risky, there often isn’t a lot of information available about how safe and effective the drugs are for pregnant or breastfeeding mothers.

Read more
The BE CARING Study for 
breastfeeding mothers

The BE CARING Study for 
breastfeeding mothers

The aim of the BE CARING Study is to gather information about the amounts of a drug called bimekizumab in the breast milk of breastfeeding mothers who are taking it for an autoimmune or autoinflammatory disease. The study will also assess the amounts of bimekizumab in the blood of the mother and (optionally) her breastfeeding baby.

Read more
clinical research

The most important people in clinical research are volunteers.

Without people like you, clinical studies could not take place.

Why the BE CARING Study?

The BE CARING Study is important because there isn’t much data available on the effects of drugs like bimekizumab on breastfeeding. The results of this study will help us understand this more fully and hopefully helping other families in the future.